Procyanidin capsules provide a new option for long-term ROS scavenging in chronic inflammatory diseases

Area of Science:

• Biomedical Engineering
• Materials Science
• Pharmacology

Background:

• Chronic inflammatory diseases, including diabetic wounds and osteoarthritis, pose significant health risks.
• Excessive reactive oxygen species (ROS) accumulation is a key factor in the pathogenesis of these conditions.
• Current treatments for long-term ROS scavenging and chronic inflammation are limited.

Purpose of the Study:

• To develop and evaluate procyanidin capsules for their ability to scavenge ROS and treat chronic inflammatory diseases.
• To assess the biosafety and therapeutic efficacy of procyanidin capsules in models of diabetic wounds and osteoarthritis.
• To investigate the molecular mechanisms underlying the therapeutic effects of procyanidin capsules.

Main Methods:

• Procyanidin capsules were synthesized using a simple one-step method with calcium carbonate as a template.
• Biosafety was evaluated through in vitro cytotoxicity assays and in vivo pathological examinations.
• Therapeutic effects were assessed via pathological evaluation, quantification of inflammatory markers, and transcriptome analysis.

Main Results:

• Procyanidin capsules demonstrated long-term ROS scavenging capabilities.
• The capsules effectively promoted articular cartilage repair in osteoarthritis models.
• Accelerated healing was observed in diabetic wound models, with regulation of AMP-activated protein kinase (AMPK) signaling.

Conclusions:

• Procyanidin capsules offer a promising therapeutic strategy for managing chronic inflammatory diseases.
• The simple synthesis protocol facilitates potential clinical translation.
• Targeting ROS with procyanidin capsules presents a novel approach for long-term disease management.